Results 221 to 230 of about 14,994,869 (262)

Sexual dysfunction in chronic hepatitis B: a comprehensive review of pathophysiology, clinical burden, and integrated management. [PDF]

Front Public Health
Muzammal S, Song CR, Peng JN, Wang YH, Chen EQ.   +4 more
europepmc   +1 more source

Quantitative HBsAg as a biomarker for disease staging in untreated chronic hepatitis B patients: a cross-sectional study. [PDF]

Front Med (Lausanne)
Mrabet S, Handous I, Trabelsi O, Maatouk Y, Harbi R, Akkari I, Hannachi N, Ben Jazia E.   +7 more
europepmc   +1 more source

Hypovitaminosis D-Induced Secondary Hyperparathyroidism With Concomitant Femoral Fracture in a Chronic Hepatitis B Patient: A Case Report. [PDF]

Clin Case Rep
Appati W, Hutton-Mensah KA, Aidoo L, Otchwemah NAS.   +3 more
europepmc   +1 more source

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. [PDF]

Front Immunol
Zhu C, Yang J, Sheng Y, Fang M.
europepmc   +1 more source

Cost-Effectiveness of Interventions to Improve Retention in Care for Chronic Hepatitis B in the United States. [PDF]

J Viral Hepat
Starinieri I, Chitnis A, Wong RJ, Yette E, Pham H, Tang AS, So S, Toy M.   +7 more
europepmc   +1 more source

Hippuric acid contributes to NK-cell activation with dependence on TLR2 in chronic hepatitis B complicated by MASLD. [PDF]

iScience
Zhang L, Li A, Xu K, Tao S, Zheng M.
europepmc   +1 more source

Interferon therapy for chronic hepatitis B in children: an immunological perspective. [PDF]

Front Immunol
Zhao Y, Wang Y, Yu G.
europepmc   +1 more source

Engineering a dual-antigen mRNA vaccine to restore immune control in chronic hepatitis B. [PDF]

Nat Commun
Zhang B, Wang Y, Chen D, Li M, Zhang J, Wu Y, Xia J, Meng X, Wang Y, Li M.   +9 more
europepmc   +1 more source